Development of Farnesyltransferase Inhibitors for Clinical Cancer Therapy: Focus on Hematologic Malignancies
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1080/07357900701359437
Reference95 articles.
1. Ras Protein Farnesyltransferase: A Strategic Target for Anticancer Therapeutic Development
2. Searching for the elusive targets of farnesyltransferase inhibitors
3. Phase II Study of the Efficacy and Tolerability of Two Dosing Regimens of the Farnesyl Transferase Inhibitor, R115777, in Advanced Breast Cancer
4. Phase II Study of the Farnesyl Transferase Inhibitor R115777 in Patients With Advanced Non–Small-Cell Lung Cancer
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. High-density lipoproteins: A promising tool against cancer;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2022-01
2. Role of Lipoproteins in the Microenvironment of Hormone-Dependent Cancers;Trends in Endocrinology & Metabolism;2020-03
3. Protein prenylation: unique fats make their mark on biology;Nature Reviews Molecular Cell Biology;2016-01-21
4. RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance;Drug Resistance Updates;2015-03
5. Evaluation of Prenylated Peptides for Use in Cellular Imaging and Biochemical Analysis;Methods in Molecular Biology;2013-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3